A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
2021 · Immunity · 105 citations
https://doi.org/10.1016/j.immuni.2021.08.016
S
Saravanan Raju
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
946
Citations
16
h-index
24
i10-index
Saravanan Raju is an academic researcher from Central Tuber Crops Research Institute. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Mosquito-borne diseases and control & T-cell and B-cell Immunology. The author has an h-index of 16, co-authored 41 publications.
ORCID: 0000-0003-3216-5574Papers by this author
worksImprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
2024 · Nature · 73 citations
https://doi.org/10.1038/s41586-024-07539-1
A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans
2023 · Science Translational Medicine · 38 citations
https://doi.org/10.1126/scitranslmed.ade8273
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
2024 · Nature Immunology · 37 citations
https://doi.org/10.1038/s41590-024-01743-x
Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus
2024 · Cell · 30 citations
https://doi.org/10.1016/j.cell.2023.11.031
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection
2023 · Cell Reports Medicine · 16 citations
https://doi.org/10.1016/j.xcrm.2023.101305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat